← Back to Search

Behavioural Intervention

Primary Care Model for Cancer Survivorship (EPICS Trial)

N/A

Waitlist Available

Led By Erin E. Hahn, PhD, MPH

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients: Adult (21+) Kaiser Permanente Southern California members diagnosed and treated for pathologically confirmed first primary early-stage breast (stage 0, I, II) or colorectal (stage I, II) cancer within Kaiser Permanente Southern California.

Completed active cancer treatment within the past 6-36 months; active treatment includes cancer-directed surgery, chemotherapy (includes Herceptin (Trastuzumab)), radiation therapy, and ovarian suppression therapy (e.g., Goserelin (Zoladex)).

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 36 months

Awards & highlights

EPICS Trial Summary

This trial looks at two different ways of providing care to cancer survivors to see which is more effective.

Who is the study for?

The EPICS Study is for adult members of Kaiser Permanente Southern California who have been treated for early-stage breast or colorectal cancer within the last 6-36 months. They must be at low risk for recurrence, able to complete surveys in English or Spanish, and have had an oncology visit. High-risk patients and those under 21 are excluded.Check my eligibility

What is being tested?

This study tests a new model where primary care is integrated into the follow-up process for cancer survivors. It compares outcomes before and after implementing this model among people who've survived early-stage breast or colorectal cancer.See study design

What are the potential side effects?

Since this trial involves a care model rather than medication, traditional side effects aren't expected. However, there may be impacts on patient satisfaction, healthcare utilization, and overall quality of life.

EPICS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 21, a member of Kaiser Permanente Southern California, and have been diagnosed and treated for early-stage breast or colorectal cancer there.

Select...

I finished my cancer treatment between 6 months and 3 years ago.

EPICS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 36 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~36 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cancer surveillance care services

Preventive care services

Secondary outcome measures

Cancer recurrence

Confidence in Managing Survivorship Care

Medical Expenditure Panel Survey (MEPS) 2016, Experiences with Cancer Supplement, Section 7, Medical Care for Cancer Module (Item #44)

+9 more

Other outcome measures

Self-reported patient demographics

EPICS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention ConditionExperimental Treatment1 Intervention

The trial will test the efficacy of an embedded primary care provider (PCP) model (experimental condition) in which PCPs are trained in survivorship and then embedded within an oncology practice to care for low-risk, early stage breast and colorectal cancer survivors who will be transitioned at 6-36 months post-treatment for comprehensive survivorship care.

Group II: Control ConditionActive Control1 Intervention

Usual care for breast and colorectal cancer survivors (oncology-led model).

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,930,703 Total Patients Enrolled

Kaiser PermanenteLead Sponsor

538 Previous Clinical Trials

24,111,378 Total Patients Enrolled

Erin E. Hahn, PhD, MPHPrincipal InvestigatorKaiser Permanente Southern California, Department of Research & Evaluation

Media Library

Embedded primary care in cancer survivorship model (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04745754 — N/A

Colorectal Cancer Research Study Groups: Intervention Condition, Control Condition

Colorectal Cancer Clinical Trial 2023: Embedded primary care in cancer survivorship model Highlights & Side Effects. Trial Name: NCT04745754 — N/A

Embedded primary care in cancer survivorship model (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04745754 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this investigation currently available to participants?

"Clinicaltrials.gov reveals that this particular trial, which was first posted on September 21st 2021, is no longer recruiting patients. However, there are currently 2395 medical studies actively searching for candidates."

Answered by AI

What is the fundamental purpose of this experiment?

"This 36-month long trial aims to enhance preventive care services. Additionally, the Medical Expenditure Panel Survey (MEPS) 2016, Experiences with Cancer Supplement's Section 7 and its 4-item Likert scale will be used to assess cancer survivorship financial burden, access to medical care, employment and employment patterns, healthcare utilization and expenditures as well as prescription drugs usage by survivors of this disease. The Patient Centered Medical Home (PCMH) Item Set is a set of 6 questions which will be added onto both adult & child versioned CAHPS Clinician & Group Surveys in order to garner more information about patient experience"

Answered by AI

How many medical establishments are offering this trial?

"This medical trial is recruiting at Kaiser Permanente Baldwin Park Medical Center Oncology Clinic in Baldwin Park, Kaiser Permanente Riverside/Palm Springs Medical Center Oncology Clinics in Riverside, and the Kaiser Permanente West Lost Angeles Medical Center Oncology Clinic in Los Angeles. Additionally, there are 13 other enrolment sites across the nation."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Engaging Primary Care in Cancer Survivorship (EPICS) Study

Erin E. Hahn 2021. "The Engaging Primary Care in Cancer Survivorship (EPICS) Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04745754.